This week brought the prospect of an improvement in Sub-Saharan Africa’s vaccine supplies, but the region is still likely to struggle to catch up with the rest of the world in the global vaccination race. Meanwhile, although we expect the fallout from the Evergrande saga to be limited, the region’s metal producers like South Africa are exposed to weakness in China’s property sector. Finally, there has been some momentum towards a debt restructuring deal for Ethiopia, but this will probably be difficult to thrash out.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services